Maslinic acid, a triterpenic anti-tumoural agent, interferes with cytoskeleton protein expression in HT29 human colon-cancer cells

Journal of Proteomics

Volumn 83, Issue , 2013, Pages 15-25

  Rufino Palomares, Eva E ^a   Reyes Zurita, Fernando J ^a   García Salguero, Leticia ^a   Mokhtari, Khalida ^a   Medina, Pedro P ^a   Lupiáñez, José A ^a   Peragón, Juan ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

Author keywords

Cytoskeleton; HT29; Maslinic acid

Indexed keywords

ACTIN RELATED PROTEIN 2; BETA ACTIN; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 2; CYTOKERATIN 8; CYTOKERATIN 9; CYTOSKELETON PROTEIN; GELSOLIN; GELSOLIN 1; KERATIN TYPE I; KERATIN TYPE II; LAMININ; LAMININ B1; MASLINIC ACID; MOESIN; SEPTIN; SEPTIN 2; UNCLASSIFIED DRUG; VILLIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; TRITERPENES;

EID: 84876300843     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.02.031     Document Type: Article

References (45)

1. Cunningham D., Atkin W., Lenz H.J., Lynch H.T., Minsky B., Nordlinger B., et al. Colorectal cancer. Lancet 2010, 20:1030-1047.
2. 13C nuclear magnetic resonance spectroscopy for determining the different components of epicuticular waxes of olive fruit (Olea europaea) Dritta cultivar. Anal Chim Acta 2008, 624:184-194.
3. Guinda A., Rada M., Delgado T., Gutiérrez-Adánez P., Castellano J.M. Pentacyclic triterpenoids from olive fruit and leaf. J Agric Food Chem 2010, 58:9685-9691.
4. Allouche Y., Jiménez A., Uceda M., Aguilera M.P., Gaforio J.J., Beltrán G. Triterpenic content and chemometric analysis of virgin olive oils for forty olive cultivars. J Agric Food Chem 2009, 57:3604-3610.
5. Rufino-Palomares E.E., Reyes-Zurita F., García-Salguero L., Peragón J., de la Higuera M., Lupiáñez J.A. Maslinic acid and ration size enhanced hepatic protein-turnover rates of gilthead sea bream (S. aurata). Aquac Nutr 2012, 18:138-151.
6. Rufino-Palomares E.E., Reyes-Zurita F., García-Salguero L., Peragón J., de la Higuera M., Lupiáñez J.A. Maslinic acid, a natural triterpene, and ration size increased growth and protein turnover of white muscle in gilthead sea bream (S. aurata). Aquac Nutr 2012, 18:568-580.
7. Rufino-Palomares EE, Reyes-Zurita F, García-Salguero L, Peragón J, de la Higuera M, Lupiáñez JA. The role of maslinic acid in the pentose phosphate pathway during growth of Gilthead Sea bream (S. aurata). Aquac Nutr in press. http://dx.doi.org/10.1111/anu.12018.
8. Rufino-Palomares E.E., Reyes-Zurita F., Fuentes-Almagro C., de la Higuera M., Lupiáñez J.A., Peragón J. Proteomics in the liver of gilthead sea bream (S. aurata) to elucidate the cellular response induced by the intake of maslinic acid. Proteomics 2011, 11:3312-3325.
9. Rodríguez-Rodríguez R., Ruiz-Gutiérrez V. Functional properties of pentacyclic triterpenes contained in pomace olive oil. Olives and olive oil in health and disease prevention 2010, 1431-1438. Academic Press/Elsevier Inc., London. V.R. Preedy, R.R. Watson (Eds.).
10. Reyes F.J., Centelles J.J., Lupiáñez J.A., Cascante M. (2α,3β)-2,3-Dihydroxyolean-12-en-28-oic acid, a new natural triterpene from Olea europaea, induces caspase dependent apoptosis selectively in colon adenocarcinoma cells. FEBS Lett 2006, 580:6302-6310.
11. Reyes-Zurita F.J., Rufino-Palomares E.E., Lupiáñez J.A., Cascante M. Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway. Cancer Lett 2009, 273:44-54.
12. Reyes-Zurita F.J., Pachón-Peña G., Lizárraga D., Rufino-Palomares E.E., Cascante M., Lupiáñez J.A. The natural triterpene maslinic acid induces apoptosis in HT29 colon cancer cells by a JNK-p53-dependent mechanism. BMC Cancer 2011, 11:154.
13. Zheng Y.K., Oegema K. Cell structure and dynamics. Curr Opin Cell Biol 2008, 20:1-3.
14. Adam Wax V.B. Biomedical applications of light scattering 2009, McGraw-Hill, Burr Ridge.
15. Frixione E. Recurring views on the structure and function of the cytoskeleton: a 300-year epic. Cell Motil Cytoskeleton 2000, 46:73-94.
16. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374.
17. Yamazaki D., Kurisu S., Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Sci 2005, 96:379-386.
18. dos Remedios C.G., Chhabra D., Kekic M., Dedova I.V., Tsubakihara M., Berry D.A., et al. Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 2003, 83:433-473.
19. Bernstein H., Payne C.M., Kunke K., Crowley-Weber C.L., Waltmire C.N., Dvorakova K., et al. A proteomic study of resistance to deoxycholate-induced apoptosis. Carcinogenesis 2004, 25:681-692.
20. Litwin M., Nowak D., Mazur A.J., Baczynska D., Mannherz H.G., Malicka-Blaszkiewicz M. Gelsolin affects the migratory ability of human colon adenocarcinoma and melanoma cells. Life Sci 2012, 90:851-861.
21. Kocevar N., Odreman F., Vindigni A., Frkovic Grazio S., Komel R. Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers. World J Gastroenterol 2012, 18:1216-1228.
22. Nishizuka S., Chen S.-T., Gwadry F.G., Alexander J., Major S.M., Scherf U., et al. Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling. Cancer Res 2003, 63:5243-5250.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
24. Comín-Anduix B., Boros L.G., Marin S., Boren J., Callol-Massot C., Centelles J.J., et al. Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumor cells. J Biol Chem 2002, 277:46408-46414.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head bacteriophate T4. Nature 1970, 227:680-685.
26. Olson M.F., Sahai E. The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis 2009, 26:273-287.
27. Litwin M., Mazur A.J., Nowak D., Mannherz H.G., Malicka-Blaszkiewicz M. Gelsolin in human colon adenocarcinoma cells with different metastatic potential. Acta Biochim Pol 2009, 56:739-743.
28. Yap W.H., Khoo K.S., Lim S.H., Yeo C.C., Lim Y.M. Proteomic analysis of the molecular response of Raji cells to maslinic acid treatment. Phytomedicine 2012, 19:183-191.
29. Wittmann-Liebold B., Graack H.R., Pohl T. Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 2006, 6:4688-4703.
30. Aebi U., Cohn J., Buhle L., Gerace L. The nuclear lamina is a meshwork of intermediate-type filaments. Nature 1986, 323:560-564.
31. Ankenbauer T., Kleinschmidt J.A., Walsh M.J., Weiner O.H., Franke W.W. Identification of a widespread nuclear actin binding protein. Nature 1989, 342:1197-1202.
32. Miller C.A., Cohen M.D., Costa M. Complexing of actin and other nuclear proteins to DNA by cis-diamminedichloroplatinum(II) and chromium compounds. Carcinogenesis 1991, 12:269-275.
33. McKeon F.D., Kirschner M.W., Caput D. Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature 1986, 319:463-468.
34. Fisher D.Z., Chaudhary N., Blobel G. cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins. Proc Natl Acad Sci USA 1986, 83:6450-6454.
35. Paulin-Levasseur M., Giese G., Scherbarth A., Traub P. Expression of vimentin and nuclear lamins during the in vitro differentiation of human promyelocyte leukemia cells HL-60. Eur J Cell Biol 1989, 50:453-461.
36. Kaufmann S.H., Mabry M., Jasti R., Shaper J.H. Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines. Cancer Res 1991, 51:581-586.
37. Cance W.G., Chadhary N., Worman H.J., Blobel G., Cordon-Cardo C. Expression of the nuclear lamins in normal and neoplastic human tissues. J Exp Clin Cancer Res 1992, 11:233-246.
38. Broers J.L.V., Raymond Y., Rot M.K., Kuijpers H., Wagenaar S.S., Ramaekers F.C. Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am J Pathol 1993, 143:211-220.
39. Moss S.F., Krivosheyev V., de Souza A., Chin K., Gaetz H.P., Chaudhary N., et al. Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms. Gut 1999, 45:723-729.
40. Kolber M.A., Broschat K.O., Landa-González B. Cytochalasin B induces cellular DNA fragmentation. FASEB J 1990, 4:3021-3027.
41. Magro F., Fraga S., Soares-da-Silva P. Interferon-γ-induced STAT1-mediated membrane retention of NHE1 and associated proteins ezrin, radixin and moesin in HT-29 cells. Biochem Pharmacol 2005, 70:1312-1319.
42. Spiliotis E.T., Kinoshita M., Nelson W.J. A mitotic septin scaffold required for mammalian chromosome congression and segregation. Science 2005, 307:1781-1785.
43. Damania D., Subramanian H., Tiwari A.K., Stypula Y., Kunte D., Pradhan P., et al. Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. Biophys J 2010, 99:989-996.
44. Gourlay C.W., Ayscough K.R. The actin cytoskeleton in ageing and apoptosis. FEMS Yeast Res 2005, 5:1193-1198.
45. Odaka C., Sanders M.L., Crews P. Jasplakinolide induces apoptosis in various transformed cell lines by a caspase-3-like protease-dependent pathway. Clin Diagn Lab Immunol 2000, 7:947-952.